How Virtual Clinical Trials are Revolutionizing Health Research

Virtual clinical trials (VCTs) are a transformative approach to clinical research that's gaining momentum in the life sciences industry. These innovative trials represent a paradigm shift, offering patient-centric, cost-effective, and time-efficient alternatives to traditional in-clinic trials. VCTs are making trials more accessible to a broader and more diverse patient population—and providing researchers with richer and more robust data.

Understanding Virtual Clinical Trials

Virtual clinical trials, often referred to as decentralized trials, are a relatively new addition to the field of health research. They leverage digital tools and technologies to collect data from participants remotely, in their natural living or working environments. This contrasts with traditional clinical trials, where participants are required to visit research facilities or clinics at regular intervals for data collection and monitoring. Virtual trials can be conducted either fully remotely or using a hybrid approach. Fully remote trials are run entirely away from clinics, with all participant interactions happening either at, or in proximity to, their homes. In contrast, hybrid trials blend traditional in-person visits to sites with remote elements.

Key Components of the VCT Ecosystem

VCTs rely on a broad range of digital tools used to engage participants, manage data, and ensure that trials run smoothly. The key VCT elements are briefly summarized below:

• eConsent: eConsent is a digital method of obtaining informed consent from participants in clinical trials. It uses interactive, multimedia tools to provide information and gather participants’ consent electronically. By allowing patients to review study protocols at their own pace, eConsent improves transparency and enhances patient understanding.
• ePRO: Electronic patient-reported outcomes (ePRO) are health outcomes or behaviors directly reported by the patient and collected electronically. ePRO tools capture data about a patient's activities and health status, including symptoms, functionality, and quality of life.
• Telemedicine: Telemedicine enables remote patient consultation and assessments, reducing the need for in-person visits and making participation more convenient for patients.
• Sensors and Wearable Devices: These devices can episodically or continuously monitor various health parameters—including heart rate, sleep patterns, and activity levels—providing rich, objective data in real time.
• Remote Patient Monitoring: This ensures the timely oversight of possible safety issues (adverse or serious adverse events) so proper actions can be taken quickly.

Comparison of Research Approaches

The following data highlights the differences between traditional and virtual trial models based on the research framework:

• Traditional Trials: Participants are required to visit research facilities or clinics at regular intervals; data collection is reserved only for site visits.
• Virtual Clinical Trials (VCTs): Participants interact from their natural living or working environments; real-time remote patient monitoring captures and addresses issues more quickly.
• Hybrid Trials: These blend traditional in-person visits to sites with remote elements.

The Virtual Research Nurse Framework in Oncology

Most cancer patients are diagnosed and treated in community oncology practices; however, their participation in clinical trials is low. A common barrier to clinical trial enrollment in the community is the lack of research infrastructure and experienced research personnel. To address this challenge, the Virtual Research Nurse (VRN) program was developed to provide virtual research support to urban and rural community oncology clinics.

In this program, a research nurse can remotely screen, enroll, and follow patients on clinical trials at distant community oncology practices. The VRN can remotely access the provider’s clinic schedule and patient medical records to identify potential trial candidates ahead of their scheduled appointment. If the patient expresses interest, they are immediately connected with the VRN by teleconference, during which the VRN explains the protocol and answers patient questions.

Transformative Impact on Recruitment and Data Quality

The use of eConsent, ePRO, telemedicine, wearable devices, and remote patient monitoring enables patients to participate in trials from their natural environments, allowing for more convenient, accurate, and efficient data collection. By offering flexibility and access, telemedicine can increase participant recruitment and retention rates in clinical trials. This technology allows researchers to gain more comprehensive insight into a participant's health and response to treatment, ultimately enhancing the quality of trial data. As VCTs continue to evolve, we will see more ways to leverage technology to offer a more inclusive and efficient research landscape.